MBTPS1 and relapsing-remitting multiple sclerosis: One of the best-studied drugs is fingolimod (FTY720), a S1P modulator that causes rapid induction of lymphopenia (Cyster and Schwab, 2012) and is approved for the treatment of relapsing-remitting multiple sclerosis (RRMS).